Login / Signup

Propolis and Its Potential to Treat Gastrointestinal Disorders.

Luisa Mota da SilvaPriscila de SouzaSoad K Al JaouniSteve M HarakehShahram GolbabapourSérgio Faloni de Andrade
Published in: Evidence-based complementary and alternative medicine : eCAM (2018)
There are a number of disorders that affect the gastrointestinal tract. Such disorders have become a global emerging disease with a high incidence and prevalence rates worldwide. Inflammatory and ulcerative processes of the stomach or intestines, such as gastritis, ulcers, colitis, and mucositis, afflict a significant proportion of people throughout the world. The role of herbal-derived medicines has been extensively explored in order to develop new effective and safe strategies to improve the available gastrointestinal therapies that are currently used in the clinical practice. Studies on the efficacy of propolis (a unique resinous aromatic substance produced by honeybees from different types of species of plants) are promising and propolis has been effective in the treatment of several pathological conditions. This review, therefore, summarizes and critiques the contents of some relevant published scientific papers (including those related to clinical trials) in order to demonstrate the therapeutic value of propolis and its active compounds in the treatment and prevention of gastrointestinal diseases.
Keyphrases
  • clinical trial
  • clinical practice
  • risk factors
  • helicobacter pylori
  • oxidative stress
  • multidrug resistant
  • radiation therapy
  • amino acid
  • drug induced